Matthew Vincent Dolan

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Matthew Vincent Dolan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Vincent Dolan:

Company Role Class Num Shares Value Price $ Report Date Ownership
DEXCOM INC EVP, Strategy & Corporate Dev Common Stock 42,044 $3,654,229 $86.91 29 Jan 2025 Direct

Insider Reports Filed by Matthew Vincent Dolan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DXCM DEXCOM INC 28 Jan 2025 2 -$102,820 4 EVP, Strategy & Corporate Dev 30 Jan 2025, 18:44
DXCM DEXCOM INC 15 May 2024 1 -$306,703 4 EVP Strategy and Corporate Dev 16 May 2024, 16:04
DXCM DEXCOM INC 15 Apr 2024 1 -$274,242 4 EVP Strategy and Corporate Dev 16 Apr 2024, 16:16
DXCM DEXCOM INC 15 Mar 2024 3 -$547,259 4 EVP Strategy & Corp Dev 19 Mar 2024, 16:55
DXCM DEXCOM INC 12 Mar 2024 1 -$901,896 4 EVP Strategy and Corporate 14 Mar 2024, 17:39
DXCM DEXCOM INC 08 Mar 2024 1 $0 4 EVP Strategy and Corporate 11 Mar 2024, 18:30
DXCM DEXCOM INC 01 Sep 2023 1 -$5,730 4 SVP Corporate Strategy-Develop 01 Sep 2023, 18:40
DXCM DEXCOM INC 16 Mar 2023 1 -$264,845 4 SVP Corporate Strategy-Develop 17 Mar 2023, 16:14
DXCM DEXCOM INC 10 Mar 2023 5 -$1,353,075 4 SVP Corporate Strategy-Develop 14 Mar 2023, 16:46
DXCM DEXCOM INC 08 Mar 2023 1 +$21.77 4 SVP Corporate Strategy-Develop 10 Mar 2023, 15:00
DXCM DEXCOM INC 06 Mar 2023 1 -$25,854 4 SVP Corporate Strategy-Develop 06 Mar 2023, 19:04
DXCM DEXCOM INC 01 Sep 2022 1 -$408 4 SVP Corporate Strategy-Develop 06 Sep 2022, 09:33
DXCM DEXCOM INC 15 Mar 2022 3 -$928,359 4 SVP Corporate Development 17 Mar 2022, 16:30
DXCM DEXCOM INC 08 Mar 2022 5 -$655,779 4 SVP Corporate Development 10 Mar 2022, 18:24
DXCM DEXCOM INC 04 Mar 2022 0 $0 3 Officer 10 Mar 2022, 16:39